Evidence map›Paper›PMID 40671803›Full record

ArticleResearch square2025

Elevating Jak-STAT signaling via SOCS3 deletion sustains photoreceptor viability and visual function in mouse models of retinitis pigmentosa.

Yanjie Wang, Steven Nusinowitz, Xian-Jie Yang

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The role of inflammation in myopic retinopathy.Frontiers in ophthalmology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Yanjie WangUniversity of California, Los Angeles.
Steven NusinowitzUniversity of California, Los Angeles.
Xian-Jie YangUniversity of California, Los Angeles.

Funding

Vision Research Core at UCLAP30EY000331 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DAVID S WILLIAMS · 1985 to 2026
$16.8M
Neuroprotection Mechanism for PhotoreceptorsR01EY026319 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, XIAN-JIE · 2016 to 2025
$4.1M
NEI NIH HHS P30 EY000331NEI NIH HHS R01 EY026319
6 · The paper itself

Abstract

Retinitis pigmentosa (RP) is an inherited retinal disease in which the loss of rod photoreceptors precedes cone photoreceptor degeneration. The neurocytokine ciliary neurotrophic factor (CNTF) can provide potent neuroprotection for photoreceptors in various retinal degeneration models and has thus been tested in clinical trials aimed at treating blinding diseases. In a preclinical model of RP, exogenous CNTF signaling mediated by the cytokine receptor gp130 initially triggered STAT3 and ERK phosphorylation in Muller glial cells and subsequently activated STAT3 in rods to promote photoreceptor survival. However, despite enhancing photoreceptor viability, the constitutive expression of exogenous CNTF perturbs the retinal transcriptome and further suppresses visual function. Activated STAT3 upregulates suppressor of cytokine signaling 3 (SOCS3), which acts as a feedback inhibitor to dampen cytokine signaling. In this study, we investigated whether eliminating SOCS3 in rod cells is sufficient to increase endogenous STAT3 signaling and enhance photoreceptor viability without exogenous CNTF. We show that rod-specific SOCS3 deletion attenuates photoreceptor degeneration and improves cone cell morphology in both the Pde6b/rd10 and Prph2(P216L)/rds mouse models of RP. SOCS3 ablation in rods not only causes STAT3 activation in rod photoreceptors but also leads to the propagation of STAT3 and ERK signaling to inner retinal cell types. Furthermore, rod SOCS3 deficiency led to improved visual function in the Pde6b/rd10 model and sustained cone function in the Prph2(P216L)/rds retina. Together, these findings demonstrate that intercellular communication occurs among retinal cells and the modulation of endogenous cytokine signaling events can be leveraged as an efficacious treatment to attenuate neuronal loss and preserve visual function.

Indexed as

CNTFMouse modelsRetinal degenerationSOCS3STAT3

Identifiers

PMID40671803
PMCPMC12265183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.